---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-013828"
form_type: "8-K"
ticker: "NSPR"
cik: "0001433607"
company_name: "InspireMD, Inc."
filed_at: "2025-09-17T23:59:59+00:00"
generated_at: "2026-05-17T06:20:52.622825+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# InspireMD Appoints Dan Dearen to Board, Replacing Thomas Kester

## Summary
- Thomas Kester resigned as Class III director effective Sept. 16, 2025; no disagreement cited.
- Danny Lee Dearen Jr. appointed Class III director, Audit Committee chair, and Compensation Committee member.
- Dearen received ~$180K equity grant (75% restricted stock, 25% stock options) vesting in one year.
- Kester received accelerated vesting, extended option expiry, and ~$120K in stock/options as separation.

## SEC filing metadata
- accession: 0001493152-25-013828
- form_type: 8-K
- ticker: NSPR
- cik: 0001433607
- company_name: InspireMD, Inc.
- filed_at: 2025-09-17T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1433607/000149315225013828/0001493152-25-013828-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1433607/000149315225013828/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-013828
- JSON: https://secwatch.observer/filing/0001493152-25-013828.json
- Plain text: https://secwatch.observer/filing/0001493152-25-013828.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.